Leading longevity investors by deal count (Longevity Investors Conference) 2025
Leading longevity investors by deal count (Longevity Investors Conference) 2025 by Longevity Investors Conference: 10 investors ranked, led by GV. Full list with...
- Publisher
- Longevity Investors Conference
- Published
- July 4, 2025
- On this page
- 10 of 10 ranked
- Method
- Data
- Reliability
- Grade C
GV leads with 81 longevity deals, ahead of ARCH Venture Partners (52) and Casdin Capital (49). The NIH appears 9th with 25 deals.
The full list
| Rank | Name |
|---|---|
| 1 | GVDeals: 81 |
| 2 | ARCH Venture PartnersDeals: 52 |
| 3 | Casdin CapitalDeals: 49 |
| 4 | Polaris PartnersDeals: 39 |
| 5 | Alexandria Venture InvestmentsDeals: 38 |
| 6 | Khosla VenturesDeals: 38 |
| 7 | Perceptive AdvisorsDeals: 32 |
| 8 | Foresite CapitalDeals: 26 |
| 9 | National Institutes of Health (NIH)Deals: 25 |
| 10 | OrbiMedDeals: 25 |
This list is reproduced as Longevity Investors Conference published it. Names are shown as printed. The ranking belongs to its publisher.
Sources and known limits
A reviewed date is not available for this page.